CCN1 Polyclonal Antibody

$U251 lysates probed with Cry61 Polyclonal Antibody, Unconjugated (bs-1290R) at 1:300 overnight at 4\u02daC. Followed by a conjugated secondary antibody at 1:5000 for 90 min at 37\u02daC.$

U251 lysates probed with Cry61 Polyclonal Antibody, Unconjugated (bs-1290R) at 1:300 overnight at 4\u02daC. Followed by a conjugated secondary antibody at 1:5000 for 90 min at 37\u02daC.

$Paraformaldehyde-fixed, paraffin embedded (Human kidney); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37\u00b0C for 30min; Antibody incubation with (Cyr61) Polyclonal Antibody, Unconjugated (bs-1290R) at 1:200 overnight at 4\u00b0C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.$

Paraformaldehyde-fixed, paraffin embedded (Human kidney); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37\u00b0C for 30min; Antibody incubation with (Cyr61) Polyclonal Antibody, Unconjugated (bs-1290R) at 1:200 overnight at 4\u00b0C, followed by operating according to SP Kit(Rabbit) (sp-0023) instructionsand DAB staining.

$Lane 1: Human Huvec cell lysates; Lane 2: Human A431 cell lysates probed with CCN1\/Cyr61 Polyclonal Antibody, Unconjugated (bs-1290R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.$

Lane 1: Human Huvec cell lysates; Lane 2: Human A431 cell lysates probed with CCN1\/Cyr61 Polyclonal Antibody, Unconjugated (bs-1290R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37\u02daC.

Applications

WB
IHC-P
IHC-F
IF

Reactivity

Human

Predicted Reactivity

Mouse
Rat
Dog
Cow
Sheep
Horse

Overview
Catalog #	bs-1290R
Product Name	CCN1 Polyclonal Antibody
Applications	WB IHC-P IHC-F IF
Reactivity	Human
Predicted Reactivity	Mouse, Rat, Dog, Cow, Sheep, Horse
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human Cyr61
Immunogen Range	251-379/379
Clonality	Polyclonal
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	3491
Swiss Prot	O00622
Subcellular location	Secreted
Synonyms	CCN1; GIG1; IGFBP10; Protein CYR61; CCN family member 1; Cysteine-rich angiogenic inducer 61; Insulin-like growth factor-binding protein 10; IBP-10; IGF-binding protein 10; IGFBP-10; Protein GIG1; CYR61
Background	Promotes cell proliferation, chemotaxis, angiogenesis and cell adhesion. Appears to play a role in wound healing by up-regulating, in skin fibroblasts, the expression of a number of genes involved in angiogenesis, inflammation and matrix remodeling including VEGA-A, VEGA-C, MMP1, MMP3, TIMP1, uPA, PAI-1 and integrins alpha-3 and alpha-5. CYR61-mediated gene regulation is dependent on heparin-binding. Down-regulates the expression of alpha-1 and alpha-2 subunits of collagen type-1. Promotes cell adhesion and adhesive signaling through integrin alpha-6/beta-1, cell migration through integrin alpha-v/beta-5 and cell proliferation through integrin alpha-v/beta-3.
Application Dilution
WB	1:300-5000
IHC-P	ELISA1:500-1000
IHC-F
IF